Brad Geddes
Plus aucun poste en cours
Profil
Brad Geddes is the founder of Resilience Therapeutics, Inc. He previously worked as a Senior Director of Drug Discovery at Elixir Pharmaceuticals, Inc. and as a Principal at MDS Proteomics, Inc. He also worked as a Principal at Millennium Pharmaceuticals, Inc. for a brief period.
Dr. Geddes received his undergraduate and graduate degrees from the University of Guelph and his doctorate from the University of Bristol.
Anciens postes connus de Brad Geddes
| Sociétés | Poste | Fin |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2003 |
Resilience Therapeutics, Inc.
 Resilience Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Resilience Therapeutics, Inc. operates as a pharmaceuticals store. The company was founded by Retsina Meyer, Brad Geddes and Veronica Weiner and is headquartered in Duxbury, MA. | Fondateur | - |
| MDS Proteomics, Inc. | Corporate Officer/Principal | - |
Elixir Pharmaceuticals, Inc.
 Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Brad Geddes
| University of Guelph | Graduate Degree |
| University of Bristol | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | Miscellaneous |
| MDS Proteomics, Inc. | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Resilience Therapeutics, Inc.
Resilience Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Resilience Therapeutics, Inc. operates as a pharmaceuticals store. The company was founded by Retsina Meyer, Brad Geddes and Veronica Weiner and is headquartered in Duxbury, MA. | Health Technology |